Rabbit Anti-Tyrosine Hydroxylase, phospho (Ser40) Polyclonal Antibody, Unconjugated from IMGENEX

Products	Rabbit Anti-Tyrosine Hydroxylase, phospho (Ser40) Polyclonal Antibody, Unconjugated from IMGENEX
Company	IMGENEX
Item	Rabbit Anti-Tyrosine Hydroxylase, phospho (Ser40) Polyclonal Antibody, Unconjugated
Price	$295.00
Description	Antigen Afinity Purified Tyrosine Hydroxylase (Ser40) Polyclonal Antibody This polyclonal antibody was raised against synthetic phosphopeptide corresponding to amino acids residues surrounding the phospho-Ser40 of rat Tyrosine Hydroxylase (rTH). The antibody was purified by sequential chromatography on phospho- and non-phosphopeptide affinity columns.
Info	IMGENEX IMGENEX Corporation 11175 Flintkote Avenue, Suite E San Diego, CA 92121 Customer Service: (888) 723-4363 Fax Number: (858) 642-0937 Web Site: http://www.imgenex.com

NOTE: Price information is approximate list price and actual prices may vary.

TAG: Rabbit Anti Tyrosine Hydroxylase phospho Ser40 Polyclonal Antibody Unconjugated from IMGENEX

Anti-Human Amyloid beta [1-16] Monoclonal Antibody, Unconjugated, Clone 6E10 from Cell Sciences

Anti-HES-1 Antibody, Unconjugated from CHEMICON

Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam

Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON

Biology Products:

Anti-Human Amyloid beta [1-16] Monoclonal Antibody, Unconjugated, Clone 6E10 from Cell Sciences Anti-HES-1 Antibody, Unconjugated from CHEMICON Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON

(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest

(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod

(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege

Breaking Biology News(10 mins):Stem cells battle for space 2 How to read brain activity? 2 Papillomavirus silences innate immune response 2 Urban Caucus Chair Urges Caucus Members to Get the Job Done for Health Care Reform 51283 1 Urban Caucus Chair Urges Caucus Members to Get the Job Done for Health Care Reform 51283 2 VA Advisory Committee on Women Veterans Visits Dallas 51281 1 VA Advisory Committee on Women Veterans Visits Dallas 51281 2 RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 1 RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 2

[0] Stem cells battle for space [0] How to read brain activity?[0] Papillomavirus silences innate immune response

...ecember 5, 2007, 2007) In the wake of a study tha...y by Cross River gorillas to ward off threats by h... today new field surveys to better protect this mo...arlier this year in the Journal of Primatology, fo...and clumps of grass when threatened by people. Go...

...5 December 2007 - If you needed to see a specimen ..., would you know where to look? Finding a natural...icular time or place right now is mostly a matter ...n Facility (GBIF), Biodiversity Information Standa...are paving the way for more effective internationa...

... After an injury, the body grows new blood vessels...growth causes problems, as when new blood vessels ... blindness if not treated. , A protein called CIB...orth Carolina at Chapel Hill School of Medicine ap...d vessel growth, offering a target for drug treatm...

Other Biology News:GBIF making the search for biodiversity research resources easier 2 Protein controls blood vessel formation, offers new drug target 2

World's most endangered gorilla fights back GBIF making the search for biodiversity research resources easier Protein controls blood vessel formation, offers new drug target

(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1

(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,

(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a

(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind

Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2 Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3 S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2 S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3 S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4 S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5 Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2 Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3 Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2 Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3

[0] Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies [0] S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders [0] Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List [0] Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit